SCM
FHTX icon

Sterling Capital Management’s Foghorn Therapeutics FHTX Stock Holding History

Sterling Capital Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.33K Sell
488
-359
-42% -$1.97K ﹤0.01% 2964
2025
Q4 		$4.57K Buy
847
+92
+12% +$417 ﹤0.01% 2916
2025
Q3 		$3.69K Buy
755
+547
+263% +$2.9K ﹤0.01% 2852
2025
Q2 		$978 Buy
208
+20
+11% +$84 ﹤0.01% 3067
2025
Q1 		$686 Sell
188
-166
-47% -$757 ﹤0.01% 2907
2024
Q4 		$1.67K Buy
354
+306
+638% +$2.23K ﹤0.01% 2825
2024
Q3 		$447 Buy
+48
New +$348 ﹤0.01% 2922

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Sterling Capital Management's FHTX Position: Q1 2026 in Review

Sterling Capital Management reduced its Foghorn Therapeutics (FHTX) stake by 42% in Q1 2026, selling an estimated $1.97K and leaving 488 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2964.

Sterling Capital Management first reported a position in FHTX in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.57K in Q4 2025. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Sterling Capital Management held 488 shares of Foghorn Therapeutics worth $2.33K as of Q1 2026.
  • Sterling Capital Management sold 359 Foghorn Therapeutics shares in Q1 2026, an estimated $1.97K.
  • Foghorn Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2964 holding.
  • Sterling Capital Management first reported a position in Foghorn Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Foghorn Therapeutics position peaked at $4.57K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.